456 related articles for article (PubMed ID: 17481801)
1. Current clinical management of anti-Kell alloimmunization in pregnancy.
Santiago JC; Ramos-Corpas D; Oyonarte S; Montoya F
Eur J Obstet Gynecol Reprod Biol; 2008 Feb; 136(2):151-4. PubMed ID: 17481801
[TBL] [Abstract][Full Text] [Related]
2. Obstetric history and antibody titer in estimating severity of Kell alloimmunization in pregnancy.
van Wamelen DJ; Klumper FJ; de Haas M; Meerman RH; van Kamp IL; Oepkes D
Obstet Gynecol; 2007 May; 109(5):1093-8. PubMed ID: 17470588
[TBL] [Abstract][Full Text] [Related]
3. Management of pregnancies complicated by anti-E alloimmunization.
Joy SD; Rossi KQ; Krugh D; O'Shaughnessy RW
Obstet Gynecol; 2005 Jan; 105(1):24-8. PubMed ID: 15625137
[TBL] [Abstract][Full Text] [Related]
4. Kell alloimmunization in pregnancy: associated with fetal thrombocytopenia?
van den Akker ES; Klumper FJ; Brand A; Kanhai HH; Oepkes D
Vox Sang; 2008 Jul; 95(1):66-9. PubMed ID: 18435678
[TBL] [Abstract][Full Text] [Related]
5. Kell alloimmunization, hemolytic disease of the newborn, and perinatal management.
Wenk RE; Goldstein P; Felix JK
Obstet Gynecol; 1985 Oct; 66(4):473-6. PubMed ID: 3931011
[TBL] [Abstract][Full Text] [Related]
6. [Haemolytic disease of the newborn--from a mother with anti-Kell, anti-E and anti-Vel anti-erythrocyte alloantibodies].
Vućinović M; Jadrić H; Karelović D; Roje D; Haspl-Hundrić Z; Hrgović Z; Vućinović Z
Z Geburtshilfe Neonatol; 2004 Oct; 208(5):197-202. PubMed ID: 15508054
[TBL] [Abstract][Full Text] [Related]
7. Maternal Kell blood group alloimmunization.
Bowman JM; Pollock JM; Manning FA; Harman CR; Menticoglou S
Obstet Gynecol; 1992 Feb; 79(2):239-44. PubMed ID: 1731292
[TBL] [Abstract][Full Text] [Related]
8. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
[TBL] [Abstract][Full Text] [Related]
9. Management of anti-Jka alloimmunization.
Franco A; Rossi K; Krugh D; O'Shaughnessy R
J Reprod Med; 2009 Mar; 54(3):121-5. PubMed ID: 19370894
[TBL] [Abstract][Full Text] [Related]
10. Implementation of routine screening for Kell antibodies: does it improve perinatal survival?
Kamphuis MM; Lindenburg I; van Kamp IL; Meerman RH; Kanhai HH; Oepkes D
Transfusion; 2008 May; 48(5):953-7. PubMed ID: 18248569
[TBL] [Abstract][Full Text] [Related]
11. Predicting anti-Kell-mediated hemolytic disease of the fetus and newborn: diagnostic accuracy of laboratory management.
Slootweg YM; Lindenburg IT; Koelewijn JM; Van Kamp IL; Oepkes D; De Haas M
Am J Obstet Gynecol; 2018 Oct; 219(4):393.e1-393.e8. PubMed ID: 30063902
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors and management in pregnancies complicated with severe kell alloimmunization: experiences of the last 13 years.
Babinszki A; Lapinski RH; Berkowitz RL
Am J Perinatol; 1998; 15(12):695-701. PubMed ID: 10333397
[TBL] [Abstract][Full Text] [Related]
13. Treatment of fetal anemia due to red-cell alloimmunization with intrauterine transfusions in the Netherlands, 1988-1999.
van Kamp IL; Klumper FJ; Meerman RH; Oepkes D; Scherjon SA; Kanhai HH
Acta Obstet Gynecol Scand; 2004 Aug; 83(8):731-7. PubMed ID: 15255845
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia.
Vaughan JI; Manning M; Warwick RM; Letsky EA; Murray NA; Roberts IA
N Engl J Med; 1998 Mar; 338(12):798-803. PubMed ID: 9504940
[TBL] [Abstract][Full Text] [Related]
15. [Blood group immunization: results of treatment of fetal anemia with intra-uterine intravascular blood transfusion in the Netherlands, 1987-1995].
van Kamp IL; Klumper FJ; Meerman RH; Brand A; Bennebroek Gravenhorst J; Kanhai HH
Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2527-31. PubMed ID: 10627756
[TBL] [Abstract][Full Text] [Related]
16. The clinical outcome of non-RhD antibody affected pregnancies in Northern Ireland.
Chandrasekar A; Morris KG; Tubman TR; Tharma S; McClelland WM
Ulster Med J; 2001 Nov; 70(2):89-94. PubMed ID: 11795772
[TBL] [Abstract][Full Text] [Related]
17. [Kell alloimmunization in pregnancy].
Gariod S; Brossard Y; Poissonnier MH; Vuilliez B; Deutsch V; Jouk PS; Pons JC
J Gynecol Obstet Biol Reprod (Paris); 2004 Nov; 33(7):637-48. PubMed ID: 15550883
[TBL] [Abstract][Full Text] [Related]
18. Decreased fetal erythropoiesis and hemolysis in Kell hemolytic anemia.
Weiner CP; Widness JA
Am J Obstet Gynecol; 1996 Feb; 174(2):547-51. PubMed ID: 8623782
[TBL] [Abstract][Full Text] [Related]
19. [Perinatal research on feto-maternal anti-Kell immunization].
Gavriil P; Jauniaux E; Lambermont M; Donner C; Avni FE; Rodesch F
J Gynecol Obstet Biol Reprod (Paris); 1989; 18(6):761-4. PubMed ID: 2689503
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietic suppression in fetal anemia because of Kell alloimmunization.
Vaughan JI; Warwick R; Letsky E; Nicolini U; Rodeck CH; Fisk NM
Am J Obstet Gynecol; 1994 Jul; 171(1):247-52. PubMed ID: 8030708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
